Merck & Co.’s new antibody is showing great promise in treating the Clostridium difficile bacterium, according to Reuters. In these trial studies,...
Researchers report that two new cancer immunotherapy drugs in development by Bristol-Myers Squibb and Merck that free the immune system to fight...